Our department has extensive experience over the past 25 years in industry-sponsored multi-center clinical trials.
Our innovative research methods are unmatched in helping sponsors meet their research goals. By exploring the brain science, genetics, and neurobiology of psychiatric disorders, the MGH CTNI has been instrumental in the development of novel treatments and surrogate markers of illness and therapeutic response. Our pioneering scientific and clinical research has been instrumental in defining the standards for the state-of-the-art practice of psychiatry.
Working with the MGH CTNI, sponsors collaborate with researchers who are recognized as world leaders in many areas of psychiatric research, including anxiety, depression, bipolar disorder, women’s mental health, schizophrenia, geriatrics/ Alzheimer’s disease, phamacogenetics, neuroimaging, and pediatric psychopharmacology. MGH psychiatrists are currently serving as principal investigators or site investigators on over 50 industry sponsored clinical trials across the spectrum. They have taken on leadership roles in many of today’s most significant multicenter trials.